Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.26 USD | -0.16% | -1.57% | -28.62% |
Mar. 27 | MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products | MT |
Mar. 27 | MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit | DJ |